BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/21/2023 9:17:20 AM | Browse: 196 | Download: 180
 |
Received |
|
2022-12-28 05:16 |
|
Peer-Review Started |
|
2022-12-28 05:17 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-01-31 08:47 |
|
Revised |
|
2023-02-24 10:37 |
|
Second Decision |
|
2023-04-13 03:05 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2023-04-13 09:19 |
|
Articles in Press |
|
2023-04-13 09:19 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-06-14 07:34 |
|
Publish the Manuscript Online |
|
2023-06-21 09:17 |
| ISSN |
2220-3249 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Infectious Diseases |
| Manuscript Type |
Review |
| Article Title |
Impacts of SARS-CoV-2 on diabetes mellitus: A pre and post pandemic evaluation
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
A H M Nurun Nabi, Akio Ebihara and Hossain Uddin Shekhar |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Hossain Uddin Shekhar, PhD, Professor, Department of Biochemistry and Molecular Biology, University of Dhaka, Curzon Hall Street, Dhaka 1000, Bangladesh. hossainshekhar@du.ac.bd |
| Key Words |
Coronavirus; SARS-CoV-2; Diabetes; MERS; SARS; Single nucleotide polymorphism |
| Core Tip |
The coronavirus disease 2019 (COVID-19) pandemic caused by the novel beta coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) crippled the whole world and has resulted in large number of morbidity and mortality. The origin of the SARS-CoV-2 is still disputed. The risk of infection with SARS-CoV-2 is dependent on several risk factors as observed in many studies. The severity of the disease depends on many factors including the viral strain, host immunogenetics, environmental factors, host genetics, host nutritional status and presence of comorbidities like hypertension, diabetes, Chronic Obstructive Pulmonary Disease, cardiovascular disease, renal impairment. Diabetes is a metabolic disorder mainly characterized by hyperglycemia. Diabetic individuals are intrinsically prone to infections. SARS-CoV-2 infection in patients with diabetes result in β-cell damage and cytokine storm. Damage to the cells impairs the equilibrium of glucose, leading to hyperglycemia. The ensuing cytokine storm causes insulin resistance, especially in the muscles and liver, which also causes a hyperglycemic state. All of these increase the severity of COVID-19. Genetics also play pivotal role in disease pathogenesis. This review article focuses from the probable sources of coronaviruses and SARS-CoV-2 to its impacts on individuals with diabetes and host genetics in pre- and post-pandemic era. |
| Publish Date |
2023-06-21 09:17 |
| Citation |
Nabi AHMN, Ebihara A, Shekhar HU. Impacts of SARS-CoV-2 on diabetes mellitus: A pre and post pandemic evaluation. World J Virol 2023; 12(3): 151-171 |
| URL |
https://www.wjgnet.com/2220-3249/full/v12/i3/151.htm |
| DOI |
https://dx.doi.org/10.5501/wjv.v12.i3.151 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
